Roivant Sciences Ltd (NASDAQ: ROIV) is -8.37% lower on its value in year-to-date trading and has touched a low of $9.69 and a high of $13.06 in the current 52-week trading range. The question becomes, what are the chances the stock will make a comeback and enjoy potential growth. Why not look at analysts view on what the future holds for the stock. The ROIV stock was last observed hovering at around $10.70 in the last trading session, with the day’s gains setting it 0.14%.
Currently trading at $10.84, the stock is -2.23% and -7.07% below its SMA20 and SMA50 respectively. However, with a daily trading volume of 4.35 million and changing 1.31% at the moment leaves the stock -4.78% off its SMA200. ROIV registered 7.86% gain for a year compared to 6-month gain of 3.14%. The firm has a 50-day simple moving average (SMA 50) of $11.6742 and a 200-day simple moving average (SMA200) of $11.3817.
The stock witnessed a -10.26% loss in the last 1 month and extending the period to 3 months gives it a -6.15%, and is -2.78% down over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 2.34% over the week and 2.80% over the month.
Roivant Sciences Ltd (ROIV) has around 908 employees, a market worth around $7.89B and $125.68M in sales. Current P/E ratio is 1.92. Profit margin for the company is 3827.42%. Distance from 52-week low is 11.87% and -16.97% from its 52-week high. The company has generated returns on investments over the last 12 months (92.57%).
with sales reaching $4.75M over the same period.The EPS is expected to shrink by -114.65% this year, but quarterly earnings will post -4.28% year-over-year. Quarterly sales are estimated to shrink -87.21% in year-over-year returns.
Roivant Sciences Ltd (ROIV) Top Institutional Holders
395.0 institutions hold shares in Roivant Sciences Ltd (ROIV), with institutional investors hold 109.07% of the company’s shares. The shares outstanding are 733.33M, and float is at 448.17M with Short Float at 10.01%. Institutions hold 79.53% of the Float.
The top institutional shareholder in the company is SB INVESTMENT ADVISERS (UK) LTD with over 71.36 million shares valued at $754.29 million. The investor’s holdings represent 8.8884% of the ROIV Shares outstanding. As of 2024-06-30, the second largest holder is VIKING GLOBAL INVESTORS LP with 69.16 million shares valued at $730.98 million to account for 8.6137 of the shares outstanding. The other top investors are QVT FINANCIAL LP which holds 66.72 million shares representing 8.3103% and valued at over $705.23 million, while FMR LLC holds 5.7982 of the shares totaling 46.55 million with a market value of $492.05 million.
Roivant Sciences Ltd (ROIV) Insider Activity
The most recent transaction is an insider sale by Venker Eric, the company’s President & COO. SEC filings show that Venker Eric sold 100,000 shares of the company’s common stock on Jan 21 ’25 at a price of $11.28 per share for a total of $1.13 million. Following the sale, the insider now owns 0.73 million shares.
Still, SEC filings show that on Jan 13 ’25, Roivant Sciences Ltd. (Director) acquired 16,845,010 shares at an average price of $20.00 for $336.9 million. The insider now directly holds 96,650,341 shares of Roivant Sciences Ltd (ROIV).
